Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 5/20 | 0.34 |
| ▸ | USP7 | Q93009 | 1/20 | 0.34 |
| ▸ | GCGR | P47871 | 7/20 | 0.33 |
| ▸ | TGFBR2 | P37173 | 1/20 | 0.33 |
| ▸ | MET | P08581 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.32 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2299259 | 1.00 | TGFBR1 (0.34) | TGFBR1USP7GCGRTGFBR2MET | |
| SCHEMBL2299439 | 0.94 | MET (0.33) | TGFBR1USP7GCGRMETMEN1 | |
| SCHEMBL2298510 | 0.93 | MET (0.34) | TGFBR1USP7GCGRMETMEN1 | |
| SCHEMBL2300218 | 0.93 | USP7 (0.33) | TGFBR1USP7GCGRMETMEN1 | |
| SCHEMBL2297662 | 0.93 | USP7 (0.33) | TGFBR1USP7GCGRMETMEN1 | |
| SCHEMBL2297656 | 0.91 | USP7 (0.34) | TGFBR1USP7GCGRMETMEN1 | |
| SCHEMBL2299085 | 0.91 | USP7 (0.34) | TGFBR1USP7GCGRMETMEN1 | |
| SCHEMBL16496400 | 0.91 | USP7 (0.35) | USP7GCGRRAB9A | |
| SCHEMBL3394974 | 0.91 | USP7 (0.35) | USP7GCGRRAB9A | |
| SCHEMBL2300176 | 0.90 | USP7 (0.33) | USP7GCGRADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110312975-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | YANG ZHE (US) | 2011-12-22 | — | — | US | disclosed |
| US-20110312975-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | YANG ZHE (US) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110312975-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | TNNC1, TNNI3, TNNT2 | TGFBR1 2747/4885USP7 3466/4885GCGR 1276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.